Katharina et al. [23] identified a novel promigratory pathway of pancreatic cancer cells in which the loss of DSG2 reduces the levels of plakoglobin via deregulated MAPK signaling. The gene discussed is DSG2; the disease is familial pancreatic carcinoma.